Virtu KCG Holdings’s Ironwood Pharmaceuticals IRWD Stock Holding History

Virtu KCG Holdings’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$297K	Buy	18,794 +1,756	+10%	+$25.5K	0.01%	1681
2017 Q1	$243K	Buy	17,038 +2,899	+21%	+$39.6K	0.01%	2200
2016 Q4	$181K	Buy	+14,139	New	+$179K	﹤0.01%	2655
2016 Q2	–	Sell	-39,407	Closed	-$361K	–	3132
2016 Q1	$361K	Buy	39,407 +22,050	+127%	+$182K	0.01%	1518
2015 Q4	$168K	Buy	+17,357	New	+$168K	﹤0.01%	2805
2015 Q2	–	Sell	-14,234	Closed	-$191K	–	3530
2015 Q1	$191K	Buy	+14,234	New	+$187K	﹤0.01%	2428
2014 Q2	–	Sell	-12,586	Closed	-$130K	–	3853
2014 Q1	$130K	Buy	+12,586	New	+$142K	﹤0.01%	3135

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Virtu KCG Holdings's IRWD Position: Q2 2017 in Review

Virtu KCG Holdings increased its Ironwood Pharmaceuticals (IRWD) stake by 10% in Q2 2017, buying an estimated $25.5K and bringing the position to 18,794 shares worth $297K. The position accounts for 0.01% of the portfolio, ranked #1681.

Virtu KCG Holdings first reported a position in IRWD in Q1 2014 and has held it in 7 quarters since. The position peaked at $361K in Q1 2016. 167 funds tracked by Wall St. Rank hold IRWD as of Q2 2017.

Virtu KCG Holdings held 18,794 shares of Ironwood Pharmaceuticals worth $297K as of Q2 2017.
Virtu KCG Holdings bought 1,756 Ironwood Pharmaceuticals shares in Q2 2017, an estimated $25.5K.
Ironwood Pharmaceuticals made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1681 holding.
Virtu KCG Holdings first reported a position in Ironwood Pharmaceuticals in Q1 2014 and has held it in 7 quarters since.
Virtu KCG Holdings's Ironwood Pharmaceuticals position peaked at $361K in Q1 2016.
167 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.